Pharming Group
PHAR
9.65
-0.03
-0.31%
Pharming Group
US · PHAR
#3534 by market cap
Listed 2020
9.65
-0.03
-0.31%
Live - 5344 symbols - heartbeat 38s ago
· 2026-10-08 09:18
Pre-market
9.53
-1.28%
After-hours
9.65
0.00%
- Market cap
- 683.01M
- P/E (TTM)i
- 68.93
- P/Bi
- 2.52
- EPSi
- 0.04
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on PHAR?
Anonymous reader poll. Unscientific, not investment advice.
About Pharming Group
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST?, Joenja?, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
- Founded
- 1988
- CEO
- Mr. Fabrice Chouraqui, M.B.A.,Pharm.D.
- Employees
- 409
- Headquarters
- Leiden, Zuid-Holland, Netherlands (the)
- Fiscal year end
- 12-31
- Website
- pharming.com
Company profile
- Exchange
- US
- Symbol
- PHAR
- Market-cap rank
- #3534
- Listing date
- 2020-12-23
- Market cap
- 683.01M
- Float cap
- 672.19M
- Shares out
- 70.78M
- Float shares
- 69.66M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 09:18:35 · For reference only, not investment advice and not tailored to your situation.